scispace - formally typeset
E

Eun-Ji Park

Researcher at Daejeon University

Publications -  8
Citations -  86

Eun-Ji Park is an academic researcher from Daejeon University. The author has contributed to research in topics: Placebo & Sanguiin H-6. The author has an hindex of 4, co-authored 8 publications receiving 71 citations.

Papers
More filters
Journal ArticleDOI

Estrogenic Activity of Sanguiin H-6 through Activation of Estrogen Receptor α Coactivator-binding Site

TL;DR: Phytochemicals from Rubus coreanus that were able to disrupt ERα and coactivator interaction with an ERα antagonist were investigated and indicated that sanguiin H6 contributed to the estrogenic activity of R. coreanus through the activation of the ERα coActivator-binding site.
Journal ArticleDOI

Cytotoxic effect of sanguiin H-6 on MCF-7 and MDA-MB-231 human breast carcinoma cells.

TL;DR: It is found that sanguiin H-6 significantly reduced cell viability in a concentration-dependent manner and increased the rates at which MCF-7 and MDA-MB-231 cells underwent apoptosis.
Journal ArticleDOI

Perspectives on the Market Globalization of Korean Herbal Manufacturers: A Company-Based Survey

TL;DR: It was found that the majority of the manufacturing employee respondents were regular permanent and production workers, and the dominant product was red ginseng (hongsam), which was the most crucial limiting and challenging factors for market globalization.
Journal ArticleDOI

Danggwijagyaksan for climacteric syndrome in peri- and postmenopausal women with a blood-deficiency dominant pattern: study protocol for a randomized, double-blind, placebo-controlled pilot trial.

TL;DR: The findings of this study will provide the basis for a full-scale randomized controlled trial to confirm the safety and efficacy of DJS for the treatment of climacteric syndrome in peri- and postmenopausal women.
Journal ArticleDOI

Effects of herbal medicine (Danggwijagyaksan) for treating climacteric syndrome with a blood-deficiency-dominant pattern: A randomized, double-blind, placebo-controlled pilot trial.

TL;DR: In this paper, a pilot study aimed to evaluate the efficacy, safety and feasibility of Dangwijagyaksan (DJS) for treating menopausal symptoms with a blood-deficiency-dominant pattern.